Vincent Keereman

Vincent holds a Master in Electronics Engineering and a Master in Medicine (MD) from Ghent University. He obtained a PhD in Biomedical Engineering on the topic of PET-MR imaging in 2011 and board certification in Neurology in 2018.

Next to Xeos he is also co-founder of Molecubes and Epilog, both medtech spin-offs of Ghent University where he has a clinical advisory role. In addition to his clinical practice as a neurologist, he currently holds a position as Assistant Professor at Ghent University.

Vincent combines his medical and technical experience with a strong sense of entrepreneurship. This provides him with an ideal background to develop clinical strategy and validation paths, distill new applications from clinical need and support development from a clinical point of view. After being the CMO he became CEO of XEOS in May 2024.